A Piperidinium, 1-(3-carbamoyl-3,3-diphenylpropyl)-1-methyl-, bromide written confirmation (Piperidinium, 1-(3-carbamoyl-3,3-diphenylpropyl)-1-methyl-, bromide WC) is an official document issued by a regulatory agency to a Piperidinium, 1-(3-carbamoyl-3,3-diphenylpropyl)-1-methyl-, bromide manufacturer, verifying that the manufacturing facility of a Piperidinium, 1-(3-carbamoyl-3,3-diphenylpropyl)-1-methyl-, bromide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Piperidinium, 1-(3-carbamoyl-3,3-diphenylpropyl)-1-methyl-, bromide APIs or Piperidinium, 1-(3-carbamoyl-3,3-diphenylpropyl)-1-methyl-, bromide finished pharmaceutical products to another nation, regulatory agencies frequently require a Piperidinium, 1-(3-carbamoyl-3,3-diphenylpropyl)-1-methyl-, bromide WC (written confirmation) as part of the regulatory process.
click here to find a list of Piperidinium, 1-(3-carbamoyl-3,3-diphenylpropyl)-1-methyl-, bromide suppliers with Written Confirmation (WC) on PharmaCompass.